ZA200903810B - A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one - Google Patents

A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one

Info

Publication number: ZA200903810B
Authority: ZA; South Africa
Prior art keywords: octahydrobenzo; isoxazol; benzyl; methyl; salt
Prior art date: 2006-11-02

Application number

ZA200903810A

Other languages

English (en)

Inventor

Fabio Neggiani

Laura Dini

Original Assignee

Abiogen Pharma Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-11-02

Filing date

2009-06-01

Publication date

2010-07-28

2009-06-01 Application filed by Abiogen Pharma Spa filed Critical Abiogen Pharma Spa

2010-07-28 Publication of ZA200903810B publication Critical patent/ZA200903810B/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Epidemiology (AREA)
Hospice & Palliative Care (AREA)
Addiction (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicinal Preparation (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

ZA200903810A 2006-11-02 2009-06-01 A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one ZA200903810B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT002102A ITMI20062102A1 (it)	2006-11-02	2006-11-02	Nuovui sali di 3-benzil-2-metil-2,3,3a,4,5,6,7,7a-ottaidrobenzo-d-isossazol-4-one

Publications (1)

Publication Number	Publication Date
ZA200903810B true ZA200903810B (en)	2010-07-28

Family

ID=39145485

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
ZA200903618A ZA200903618B (en)	2006-11-02	2009-05-25	A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one
ZA200903810A ZA200903810B (en)	2006-11-02	2009-06-01	A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
ZA200903618A ZA200903618B (en)	2006-11-02	2009-05-25	A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one

Country Status (20)

Country	Link
US (2)	US20100069450A1 (xx)
EP (2)	EP2094675B1 (xx)
JP (2)	JP2010509310A (xx)
KR (2)	KR20090082452A (xx)
CN (2)	CN101535281A (xx)
AT (2)	ATE502021T1 (xx)
AU (2)	AU2007315832A1 (xx)
BR (2)	BRPI0718391A2 (xx)
CA (2)	CA2667515A1 (xx)
DE (2)	DE602007013278D1 (xx)
HR (2)	HRP20090477A2 (xx)
IL (2)	IL198444A0 (xx)
IT (1)	ITMI20062102A1 (xx)
MX (2)	MX2009004294A (xx)
NO (2)	NO20092115L (xx)
NZ (2)	NZ577978A (xx)
RS (2)	RS20090388A (xx)
RU (2)	RU2009120724A (xx)
WO (2)	WO2008053325A1 (xx)
ZA (2)	ZA200903618B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ITMI20080768A1 (it) *	2008-04-24	2009-10-25	Abiogen Pharma Spa	Procedimento per la preparazione di un composto in forma cristallina di 3-benzil-2-metil-2,3,3a,4,5,6,7,7a-ottaidro-benzo[d]isossazol-4-one
EP2112142A1 (en) *	2008-04-24	2009-10-28	Abiogen Pharma S.p.A.	Process for preparing a crystalline form compound of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one
EP2218721A1 (en) *	2009-02-11	2010-08-18	LEK Pharmaceuticals d.d.	Novel salts of sitagliptin
WO2011010332A1 (en) *	2009-07-23	2011-01-27	Abiogen Pharma S.P.A.	Process for preparing rel-(3r,3as,7as*)-3-benzyl-2-methyl-2,3, 3a,4,5,6,7,7a- octahydrobenzo[d]isoxazoi-4-one or a salt thereof
WO2016123275A1 (en) *	2015-01-30	2016-08-04	Boehringer Ingelheim International Gmbh	Aldosterone synthase inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4161595A (en) *	1978-10-02	1979-07-17	Bristol-Myers Company	Levulinic acid salt
US4419358A (en) *	1981-11-12	1983-12-06	Mead Johnson & Company	Isethionic acid salt of 9-cyclohexyl-2-propoxy-9H-purine-6-amine and compositions containing an effective bronchodilating concentration of it
GB2264299B (en) *	1992-02-19	1995-07-26	British Tech Group	Iso-oxazolidine derivatives

2006
- 2006-11-02 IT IT002102A patent/ITMI20062102A1/it unknown
2007
- 2007-10-31 CN CNA2007800406598A patent/CN101535281A/zh active Pending
- 2007-10-31 HR HR20090477A patent/HRP20090477A2/hr not_active Application Discontinuation
- 2007-10-31 AU AU2007315832A patent/AU2007315832A1/en not_active Abandoned
- 2007-10-31 WO PCT/IB2007/003291 patent/WO2008053325A1/en not_active Ceased
- 2007-10-31 RU RU2009120724/04A patent/RU2009120724A/ru not_active Application Discontinuation
- 2007-10-31 DE DE602007013278T patent/DE602007013278D1/de active Active
- 2007-10-31 CA CA002667515A patent/CA2667515A1/en not_active Abandoned
- 2007-10-31 WO PCT/IB2007/003292 patent/WO2008053326A1/en not_active Ceased
- 2007-10-31 RS RSP-2009/0388A patent/RS20090388A/sr unknown
- 2007-10-31 MX MX2009004294A patent/MX2009004294A/es not_active Application Discontinuation
- 2007-10-31 EP EP07825550A patent/EP2094675B1/en not_active Not-in-force
- 2007-10-31 BR BRPI0718391-7A patent/BRPI0718391A2/pt not_active IP Right Cessation
- 2007-10-31 JP JP2009535825A patent/JP2010509310A/ja active Pending
- 2007-10-31 BR BRPI0718392-5A patent/BRPI0718392A2/pt not_active IP Right Cessation
- 2007-10-31 NZ NZ577978A patent/NZ577978A/en unknown
- 2007-10-31 DE DE602007013801T patent/DE602007013801D1/de active Active
- 2007-10-31 AT AT07825549T patent/ATE502021T1/de not_active IP Right Cessation
- 2007-10-31 CA CA002667513A patent/CA2667513A1/en not_active Abandoned
- 2007-10-31 EP EP07825549A patent/EP2094674B1/en not_active Not-in-force
- 2007-10-31 CN CNA2007800406691A patent/CN101535282A/zh active Pending
- 2007-10-31 RS RSP-2009/0389A patent/RS20090389A/sr unknown
- 2007-10-31 KR KR1020097011322A patent/KR20090082452A/ko not_active Withdrawn
- 2007-10-31 HR HR20090470A patent/HRP20090470A2/hr not_active Application Discontinuation
- 2007-10-31 KR KR1020097011287A patent/KR20090077014A/ko not_active Withdrawn
- 2007-10-31 US US12/513,351 patent/US20100069450A1/en not_active Abandoned
- 2007-10-31 AT AT07825550T patent/ATE504578T1/de not_active IP Right Cessation
- 2007-10-31 MX MX2009004293A patent/MX2009004293A/es not_active Application Discontinuation
- 2007-10-31 AU AU2007315833A patent/AU2007315833A1/en not_active Abandoned
- 2007-10-31 JP JP2009535824A patent/JP2010509309A/ja active Pending
- 2007-10-31 RU RU2009120667/04A patent/RU2009120667A/ru not_active Application Discontinuation
- 2007-10-31 US US12/513,352 patent/US20100069451A1/en not_active Abandoned
- 2007-10-31 NZ NZ577311A patent/NZ577311A/en unknown
2009
- 2009-04-28 IL IL198444A patent/IL198444A0/en unknown
- 2009-04-28 IL IL198443A patent/IL198443A0/en unknown
- 2009-05-25 ZA ZA200903618A patent/ZA200903618B/xx unknown
- 2009-05-29 NO NO20092115A patent/NO20092115L/no not_active Application Discontinuation
- 2009-05-29 NO NO20092114A patent/NO20092114L/no not_active Application Discontinuation
- 2009-06-01 ZA ZA200903810A patent/ZA200903810B/xx unknown

Also Published As

Publication number	Publication date
ZA200903618B (en)	2010-07-28
IL198444A0 (en)	2010-02-17
HRP20090470A2 (hr)	2009-11-30
DE602007013278D1 (de)	2011-04-28
KR20090077014A (ko)	2009-07-13
EP2094674B1 (en)	2011-03-16
MX2009004293A (es)	2009-05-08
EP2094674A1 (en)	2009-09-02
NZ577978A (en)	2010-10-29
JP2010509309A (ja)	2010-03-25
HRP20090477A2 (hr)	2009-11-30
RU2009120724A (ru)	2010-12-10
WO2008053325A1 (en)	2008-05-08
RS20090389A (sr)	2010-12-31
CA2667513A1 (en)	2008-05-08
AU2007315832A1 (en)	2008-05-08
ATE502021T1 (de)	2011-04-15
WO2008053326A1 (en)	2008-05-08
ITMI20062102A1 (it)	2008-05-03
RU2009120667A (ru)	2010-12-10
BRPI0718392A2 (pt)	2013-11-26
AU2007315833A1 (en)	2008-05-08
CN101535282A (zh)	2009-09-16
JP2010509310A (ja)	2010-03-25
CN101535281A (zh)	2009-09-16
BRPI0718391A2 (pt)	2013-11-26
US20100069450A1 (en)	2010-03-18
KR20090082452A (ko)	2009-07-30
CA2667515A1 (en)	2008-05-08
RS20090388A (sr)	2010-12-31
NO20092114L (no)	2009-05-29
NZ577311A (en)	2010-10-29
DE602007013801D1 (de)	2011-05-19
EP2094675B1 (en)	2011-04-06
MX2009004294A (es)	2009-05-08
EP2094675A1 (en)	2009-09-02
NO20092115L (no)	2009-05-29
IL198443A0 (en)	2010-02-17
ATE504578T1 (de)	2011-04-15
US20100069451A1 (en)	2010-03-18

Publication	Publication Date	Title
DE602006021645D1 (de)	2011-06-09	Verfahren und Zwischenverbindungen zur Herstellung von N4-Phenyl-Quinazolin-4-Amin Derivaten
MXPA05010682A (es)	2005-12-12	Compuestos novedosos.
ATE542818T1 (de)	2012-02-15	Imidazo- und triazolopyridinverbindungen und verfahren zu deren anwendung
TW200510303A (en)	2005-03-16	Novel compounds
TW200612892A (en)	2006-05-01	Novel compounds
TW200519075A (en)	2005-06-16	Novel compounds
SE0301009D0 (sv)	2003-04-07	Novel compounds
TW200407305A (en)	2004-05-16	Novel compounds
MXPA05012680A (es)	2006-02-08	Indoles novedosos de 3-azufre sustituidos.
WO2008060621A3 (en)	2008-10-09	Aminopyrrolidines as chemokine receptor antagonists
ATE463497T1 (de)	2010-04-15	Neues 1,4-diaza-bicycloä3.2.2ünonyl-oxadiazolyl- derivat und seine medizinische verwendung
ZA200903810B (en)	2010-07-28	A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one
ATE289310T1 (de)	2005-03-15	Heteroaryl-diazabicycloalkanderivaten als cns- modulatoren
TW200745003A (en)	2007-12-16	Novel compounds
TW200624432A (en)	2006-07-16	Imidazo [1,2-a] pyridine compounds, compositions, uses and methods related thereto
GB0322510D0 (en)	2003-10-29	Novel compounds
EA200600563A1 (ru)	2006-12-29	Способ получения рензаприда и его промежуточных соединений
MY159040A (en)	2016-12-15	Compounds
HK1131142A (en)	2010-01-15	A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one
HK1131143A (en)	2010-01-15	A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one
PL2186782T3 (pl)	2014-01-31	Sposób oczyszczania produktów znakowanych radioaktywnie z zastosowaniem zmiatacza na stałym nośniku
UA94615C2 (uk)	2011-05-25	Інгібітори транспортера-1 гліцину
ATE460416T1 (de)	2010-03-15	Neuartige 1,4-diazabicycloä3.2.2ünonan-derivate und deren medizinische verwendung
SE0303451D0 (sv)	2003-12-18	New compounds
EA200800044A1 (ru)	2008-06-30	Производные 2,5-бисдиамин[1,4]бензохинона